Skip to main content
Erschienen in: Journal of Nuclear Cardiology 3/2018

01.06.2018 | Theme Article

Evolving, innovating, and revolutionary changes in cardiovascular imaging: We’ve only just begun!

verfasst von: Leslee J. Shaw, PhD, Rory Hachamovitch, MD, James K. Min, MD, Marcelo Di Carli, MD, Jennifer H. Mieres, MD, Lawrence Phillips, MD, Ron Blankstein, MD, Andrew Einstein, MD, PhD, Viviany R. Taqueti, MD, MPH, Robert Hendel, MD, Daniel S. Berman, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

In this review, we highlight the need for innovation and creativity to reinvent the field of nuclear cardiology. Revolutionary ideas brought forth today are needed to create greater value in patient care and highlight the need for more contemporary evidence supporting the use of nuclear cardiology practices. We put forth discussions on the need for disruptive innovation in imaging-guided care that places the imager as a central force in care coordination. Value-based nuclear cardiology is defined as care that is both efficient and effective. Novel testing strategies that defer testing in lower risk patients are examples of the kind of innovation needed in today’s healthcare environment. A major focus of current research is the evolution of the importance of ischemia and the prognostic significance of non-obstructive atherosclerotic plaque and coronary microvascular dysfunction. Embracing novel paradigms, such as this, can aid in the development of optimal strategies for coronary disease management. We hope that our article will spurn the field toward greater innovation and focus on transformative imaging leading the way for new generations of novel cardiovascular care.
Literatur
1.
Zurück zum Zitat Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015;372:1291-300.CrossRefPubMedPubMedCentral Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015;372:1291-300.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Investigators S-H. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 2015;385:2383-91.CrossRef Investigators S-H. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 2015;385:2383-91.CrossRef
3.
Zurück zum Zitat Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164.CrossRefPubMed Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164.CrossRefPubMed
4.
Zurück zum Zitat Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol 2012;19:1026-43.CrossRefPubMed Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol 2012;19:1026-43.CrossRefPubMed
5.
Zurück zum Zitat Rozanski A, Gransar H, Hayes SW, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 2013;61:1054-65.CrossRefPubMed Rozanski A, Gransar H, Hayes SW, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 2013;61:1054-65.CrossRefPubMed
7.
Zurück zum Zitat Patel MR, Dai D, Hernandez AF, et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J 2014;167:e846-52.CrossRef Patel MR, Dai D, Hernandez AF, et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J 2014;167:e846-52.CrossRef
8.
Zurück zum Zitat Chen MY, Rochitte CE, Arbab-Zadeh A, et al. Prognostic value of combined CT angiography and myocardial perfusion imaging versus invasive coronary angiography and nuclear stress perfusion imaging in the prediction of major adverse cardiovascular events: The CORE320 multicenter study. Radiology 2017;284:55-65.CrossRefPubMedPubMedCentral Chen MY, Rochitte CE, Arbab-Zadeh A, et al. Prognostic value of combined CT angiography and myocardial perfusion imaging versus invasive coronary angiography and nuclear stress perfusion imaging in the prediction of major adverse cardiovascular events: The CORE320 multicenter study. Radiology 2017;284:55-65.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Greenwood JP, Ripley DP, Berry C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: The CE-MARC 2 randomized clinical trial. JAMA 2016;316:1051-60.CrossRefPubMed Greenwood JP, Ripley DP, Berry C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: The CE-MARC 2 randomized clinical trial. JAMA 2016;316:1051-60.CrossRefPubMed
10.
Zurück zum Zitat Greenwood JP, Herzog BA, Brown JM, et al. Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: Long-term follow-up of a prospective, diagnostic accuracy cohort study. Ann Intern Med 2016. https://doi.org/10.7326/M15-1801.CrossRefPubMed Greenwood JP, Herzog BA, Brown JM, et al. Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: Long-term follow-up of a prospective, diagnostic accuracy cohort study. Ann Intern Med 2016. https://​doi.​org/​10.​7326/​M15-1801.CrossRefPubMed
11.
Zurück zum Zitat Greenwood JP, Motwani M, Maredia N, et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the clinical evaluation of magnetic resonance imaging in coronary heart disease (CE-MARC) Trial. Circulation 2014;129:1129-38.CrossRefPubMed Greenwood JP, Motwani M, Maredia N, et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the clinical evaluation of magnetic resonance imaging in coronary heart disease (CE-MARC) Trial. Circulation 2014;129:1129-38.CrossRefPubMed
12.
Zurück zum Zitat Steg PG, Greenlaw N, Tendera M, et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: Data from the International Observational CLARIFY Registry. JAMA Intern Med 2014;174:1651-9.CrossRefPubMed Steg PG, Greenlaw N, Tendera M, et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: Data from the International Observational CLARIFY Registry. JAMA Intern Med 2014;174:1651-9.CrossRefPubMed
13.
Zurück zum Zitat Williams MC, Hunter A, Shah ASV, et al. Use of coronary computed tomographic angiography to guide management of patients with coronary disease. J Am Coll Cardiol 2016;67:1759-68.CrossRefPubMedPubMedCentral Williams MC, Hunter A, Shah ASV, et al. Use of coronary computed tomographic angiography to guide management of patients with coronary disease. J Am Coll Cardiol 2016;67:1759-68.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Mark DB, Anderson JL, Brinker JA, et al. ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 health policy statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol 2014;63:698-721.CrossRefPubMed Mark DB, Anderson JL, Brinker JA, et al. ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 health policy statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol 2014;63:698-721.CrossRefPubMed
15.
Zurück zum Zitat Lubbers M, Coenen A, Bruning T, et al. Sex differences in the performance of cardiac computed tomography compared with functional testing in evaluating stable chest pain: Subanalysis of the multicenter, randomized CRESCENT trial (calcium imaging and selective CT angiography in comparison to functional testing for suspected coronary artery disease). Circ Cardiovasc Imaging 2017;10:e005295.CrossRefPubMed Lubbers M, Coenen A, Bruning T, et al. Sex differences in the performance of cardiac computed tomography compared with functional testing in evaluating stable chest pain: Subanalysis of the multicenter, randomized CRESCENT trial (calcium imaging and selective CT angiography in comparison to functional testing for suspected coronary artery disease). Circ Cardiovasc Imaging 2017;10:e005295.CrossRefPubMed
16.
Zurück zum Zitat Lubbers M, Dedic A, Coenen A, et al. Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: The multicentre, randomized CRESCENT trial. Eur Heart J 2016;37:1232-43.CrossRefPubMed Lubbers M, Dedic A, Coenen A, et al. Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: The multicentre, randomized CRESCENT trial. Eur Heart J 2016;37:1232-43.CrossRefPubMed
17.
Zurück zum Zitat Danad I, Raijmakers PG, Driessen RS, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol 2017;2:1100-7.CrossRefPubMed Danad I, Raijmakers PG, Driessen RS, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol 2017;2:1100-7.CrossRefPubMed
18.
Zurück zum Zitat Faner R, Cruz T, Lopez-Giraldo A, Agusti A. Network medicine, multimorbidity and the lung in the elderly. Eur Respir J 2014;44:775-88.CrossRefPubMed Faner R, Cruz T, Lopez-Giraldo A, Agusti A. Network medicine, multimorbidity and the lung in the elderly. Eur Respir J 2014;44:775-88.CrossRefPubMed
19.
Zurück zum Zitat Hecht HS, Cronin P, Blaha MJ, et al. 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Thorac Imaging 2017;32:W54-66.CrossRefPubMed Hecht HS, Cronin P, Blaha MJ, et al. 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Thorac Imaging 2017;32:W54-66.CrossRefPubMed
21.
23.
Zurück zum Zitat Moss AJ, Williams MC, Newby DE, Nicol ED. The updated NICE guidelines: Cardiac CT as the first-line test for coronary artery disease. Curr Cardiovasc Imaging Rep 2017;10:15.CrossRefPubMedPubMedCentral Moss AJ, Williams MC, Newby DE, Nicol ED. The updated NICE guidelines: Cardiac CT as the first-line test for coronary artery disease. Curr Cardiovasc Imaging Rep 2017;10:15.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Shaw LJ, Phillips LM, Nagel E, Newby DE, Narula J, Douglas PS. Comparative effectiveness trials of imaging-guided strategies in stable ischemic heart disease. JACC Cardiovasc Imaging 2017;10:321-34.CrossRefPubMed Shaw LJ, Phillips LM, Nagel E, Newby DE, Narula J, Douglas PS. Comparative effectiveness trials of imaging-guided strategies in stable ischemic heart disease. JACC Cardiovasc Imaging 2017;10:321-34.CrossRefPubMed
25.
Zurück zum Zitat Rozanski A, Gransar H, Shaw LJ, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial. J Am Coll Cardiol 2011;57:1622-32.CrossRefPubMedPubMedCentral Rozanski A, Gransar H, Shaw LJ, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial. J Am Coll Cardiol 2011;57:1622-32.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Hecht HS, Shaw LJ, Chandrashekhar Y, Narula J. Coronary artery calcium and shared decision making. JACC Cardiovasc Imaging 2016;9:637-9.CrossRefPubMed Hecht HS, Shaw LJ, Chandrashekhar Y, Narula J. Coronary artery calcium and shared decision making. JACC Cardiovasc Imaging 2016;9:637-9.CrossRefPubMed
27.
Zurück zum Zitat Hecht HS. Coronary artery calcium scanning: Past, present, and future. JACC Cardiovasc Imaging 2015;8:579-96.CrossRefPubMed Hecht HS. Coronary artery calcium scanning: Past, present, and future. JACC Cardiovasc Imaging 2015;8:579-96.CrossRefPubMed
28.
Zurück zum Zitat Taqueti VR, Everett BM, Murthy VL, et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 2015;131:528-35.CrossRefPubMed Taqueti VR, Everett BM, Murthy VL, et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 2015;131:528-35.CrossRefPubMed
29.
Zurück zum Zitat Taqueti VR, Di Carli MF. Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease. Curr Opin Cardiol 2016;31:662-9.CrossRefPubMed Taqueti VR, Di Carli MF. Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease. Curr Opin Cardiol 2016;31:662-9.CrossRefPubMed
30.
Zurück zum Zitat Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 2017;135:566-77.CrossRefPubMed Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 2017;135:566-77.CrossRefPubMed
31.
Zurück zum Zitat Taqueti VR, Dorbala S, Wolinsky D, et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol 2017;24:1402-26.CrossRefPubMedPubMedCentral Taqueti VR, Dorbala S, Wolinsky D, et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol 2017;24:1402-26.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Gupta A, Taqueti VR, van de Hoef TP, et al. Integrated non-invasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation 2017;136:2325-36.CrossRefPubMed Gupta A, Taqueti VR, van de Hoef TP, et al. Integrated non-invasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation 2017;136:2325-36.CrossRefPubMed
33.
Zurück zum Zitat Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J 2014;35:1101-11.CrossRefPubMed Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J 2014;35:1101-11.CrossRefPubMed
34.
Zurück zum Zitat Ahmadi A, Stone GW, Leipsic J, et al. Association of coronary stenosis and plaque morphology with fractional flow reserve and outcomes. JAMA Cardiol 2016;1:350-7.CrossRefPubMed Ahmadi A, Stone GW, Leipsic J, et al. Association of coronary stenosis and plaque morphology with fractional flow reserve and outcomes. JAMA Cardiol 2016;1:350-7.CrossRefPubMed
35.
Zurück zum Zitat Gaur S, Ovrehus KA, Dey D, et al. Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. Eur Heart J 2016;37:1220-7.CrossRefPubMedPubMedCentral Gaur S, Ovrehus KA, Dey D, et al. Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. Eur Heart J 2016;37:1220-7.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Shaw LJ, Mieres JH, Hendel RH, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: Results from the what is the optimal method for ischemia evaluation in women (WOMEN) trial. Circulation 2011;124:1239-49.CrossRefPubMed Shaw LJ, Mieres JH, Hendel RH, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: Results from the what is the optimal method for ischemia evaluation in women (WOMEN) trial. Circulation 2011;124:1239-49.CrossRefPubMed
37.
Zurück zum Zitat Hachamovitch R, Nutter B, Hlatky MA, et al. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012;59:462-74.CrossRefPubMed Hachamovitch R, Nutter B, Hlatky MA, et al. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012;59:462-74.CrossRefPubMed
38.
Zurück zum Zitat Cury RC, Abbara S, Achenbach S, et al. CAD-RADS(TM) coronary artery disease—reporting and data system. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 2016;10:269-81.CrossRefPubMed Cury RC, Abbara S, Achenbach S, et al. CAD-RADS(TM) coronary artery disease—reporting and data system. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 2016;10:269-81.CrossRefPubMed
39.
Zurück zum Zitat Cury RC, Abbara S, Achenbach S, et al. CAD-RADS: Coronary artery disease—reporting and data system: An expert consensus document of the society of cardiovascular computed tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Am Coll Radiol 2016;13:1458-66.CrossRefPubMed Cury RC, Abbara S, Achenbach S, et al. CAD-RADS: Coronary artery disease—reporting and data system: An expert consensus document of the society of cardiovascular computed tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Am Coll Radiol 2016;13:1458-66.CrossRefPubMed
Metadaten
Titel
Evolving, innovating, and revolutionary changes in cardiovascular imaging: We’ve only just begun!
verfasst von
Leslee J. Shaw, PhD
Rory Hachamovitch, MD
James K. Min, MD
Marcelo Di Carli, MD
Jennifer H. Mieres, MD
Lawrence Phillips, MD
Ron Blankstein, MD
Andrew Einstein, MD, PhD
Viviany R. Taqueti, MD, MPH
Robert Hendel, MD
Daniel S. Berman, MD
Publikationsdatum
01.06.2018
Verlag
Springer US
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2018
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1225-8

Weitere Artikel der Ausgabe 3/2018

Journal of Nuclear Cardiology 3/2018 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.